Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Risk factors for foot ulceration in adults with end-stage renal disease on dialysis: a prospective observational cohort study.

Kaminski MR, Lambert KA, Raspovic A, McMahon LP, Erbas B, Mount PF, Kerr PG, Landorf KB.

BMC Nephrol. 2019 Nov 21;20(1):423. doi: 10.1186/s12882-019-1594-5.

2.

Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey.

Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Davison SN, Ghnaimat M, Harden P, Htay H, Jha V, Kalantar-Zadeh K, Kerr PG, Klarenbach S, Kovesdy CP, Luyckx VA, Neuen BL, O'Donoghue D, Ossareh S, Perl J, Rashid HU, Rondeau E, See E, Saad S, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Turan Kazancioglu R, Wang AY, Wiebe N, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Caskey F, Perkovic V, Jindal KK, Okpechi IG, Tonelli M, Feehally J, Harris DC, Johnson DW.

BMJ. 2019 Oct 31;367:l5873. doi: 10.1136/bmj.l5873.

3.

mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans.

Puelles VG, van der Wolde JW, Wanner N, Scheppach MW, Cullen-McEwen LA, Bork T, Lindenmeyer MT, Gernhold L, Wong MN, Braun F, Cohen CD, Kett MM, Kuppe C, Kramann R, Saritas T, van Roeyen CR, Moeller MJ, Tribolet L, Rebello R, Sun YB, Li J, Müller-Newen G, Hughson MD, Hoy WE, Person F, Wiech T, Ricardo SD, Kerr PG, Denton KM, Furic L, Huber TB, Nikolic-Paterson DJ, Bertram JF.

JCI Insight. 2019 Sep 19;4(18). pii: 99271. doi: 10.1172/jci.insight.99271.

4.

Isolated proteinuria due to CUBN homozygous mutation - challenging the investigative paradigm.

Jayasinghe K, White SM, Kerr PG, MacGregor D, Stark Z, Wilkins E, Simons C, Mallett A, Quinlan C.

BMC Nephrol. 2019 Aug 22;20(1):330. doi: 10.1186/s12882-019-1474-z.

5.

Functional sustainability of nutrient accumulation by periphytic biofilm under temperature fluctuations.

Sun R, Xu Y, Wu Y, Tang J, Esquivel-Elizondo S, Kerr PG, Staddon PL, Liu J.

Environ Technol. 2019 Aug 27:1-10. doi: 10.1080/09593330.2019.1659422. [Epub ahead of print]

PMID:
31437081
6.

The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study.

Zimbudzi E, Lo C, Robinson T, Ranasinha S, Teede HJ, Usherwood T, Polkinghorne KR, Kerr PG, Fulcher G, Gallagher M, Jan S, Cass A, Walker R, Russell G, Johnson G, Zoungas S.

PLoS One. 2019 Jul 15;14(7):e0219685. doi: 10.1371/journal.pone.0219685. eCollection 2019.

7.

Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD): establishing a core outcome set for trials in patients with glomerular disease.

Carter SA, Lightstone L, Cattran D, Bagga A, Barbour SJ, Barratt J, Boletis J, Caster D, Coppo R, Fervenza FC, Floege J, Hladunewich M, Hogan JJ, Kitching AR, Lafayette R, Malvar A, Radhakrishnan J, Rovin BH, Zhang H, Gutman T, Howell M, Logeman C, Shen JI, Teixeira-Pinto A, Alexander SI, Cho Y, Craig JC, Harris D, Johnson DW, Kerr PG, Ryan J, Viecelli AK, Wang AY, Wilkie M, Scholes-Robertson N, Tong A; SONG-GD Initiative.

Kidney Int. 2019 Jun;95(6):1280-1283. doi: 10.1016/j.kint.2019.01.047. No abstract available.

PMID:
31122702
8.

The Use of Live Cell Imaging and Automated Image Analysis to Assist With Determining Optimal Parameters for Angiogenic Assay in vitro.

Huuskes BM, DeBuque RJ, Kerr PG, Samuel CS, Ricardo SD.

Front Cell Dev Biol. 2019 Apr 10;7:45. doi: 10.3389/fcell.2019.00045. eCollection 2019.

9.

A need-based approach to self-management education for adults with co-morbid diabetes and chronic kidney disease.

Zimbudzi E, Lo C, Kerr PG, Zoungas S.

BMC Nephrol. 2019 Apr 2;20(1):113. doi: 10.1186/s12882-019-1296-z.

10.

Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.

Viecelli AK, Polkinghorne KR, Pascoe EM, Paul-Brent PA, Hawley CM, Badve SV, Cass A, Hooi LS, Kerr PG, Mori TA, Ong LM, Voss D, Johnson DW, Irish AB; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

PLoS One. 2019 Mar 26;14(3):e0213274. doi: 10.1371/journal.pone.0213274. eCollection 2019.

11.

Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project.

Htay H, Alrukhaimi M, Ashuntantang GE, Bello AK, Bellorin-Font E, Benghanem Gharbi M, Braam B, Feehally J, Harris DC, Jha V, Jindal K, Kalantar-Zadeh K, Kazancioglu R, Kerr PG, Levin A, Lunney M, Okpechi IG, Olah ME, Olanrewaju TO, Osman MA, Parpia Y, Perl J, Qarni B, Rashid HU, Rateb A, Rondeau E, Salako BL, Sola L, Tchokhonelidze I, Tonelli M, Wiebe N, Wirzba I, Yang CW, Ye F, Zemchenkov A, Zhao MH, Johnson DW.

Kidney Int Suppl (2011). 2018 Feb;8(2):64-73. doi: 10.1016/j.kisu.2017.10.010. Epub 2018 Jan 19. Review.

12.

Global overview of health systems oversight and financing for kidney care.

Bello AK, Alrukhaimi M, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Braam B, Feehally J, Harris DC, Jha V, Jindal K, Johnson DW, Kalantar-Zadeh K, Kazancioglu R, Kerr PG, Lunney M, Olanrewaju TO, Osman MA, Perl J, Rashid HU, Rateb A, Rondeau E, Sakajiki AM, Samimi A, Sola L, Tchokhonelidze I, Wiebe N, Yang CW, Ye F, Zemchenkov A, Zhao MH, Levin A.

Kidney Int Suppl (2011). 2018 Feb;8(2):41-51. doi: 10.1016/j.kisu.2017.10.008. Epub 2018 Jan 19. Review.

13.

Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.

Cho Y, Sautenet B, Gutman T, Rangan G, Craig JC, Ong AC, Chapman A, Ahn C, Coolican H, Kao JT, Gansevoort R, Perrone RD, Harris T, Torres V, Pei Y, Kerr PG, Ryan J, Johnson DW, Viecelli AK, Geneste C, Kim H, Kim Y, Oh YK, Teixeira-Pinto A, Logeman C, Howell M, Ju A, Manera KE, Tong A.

Nephrology (Carlton). 2019 Dec;24(12):1214-1224. doi: 10.1111/nep.13566. Epub 2019 May 2.

PMID:
30663163
14.

Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede HJ, Kerr PG, Ranasinha S, Cass A, Fulcher G, Gallagher M, Polkinghorne KR, Russell G, Usherwood T, Walker R, Zoungas S.

J Diabetes Complications. 2019 Jan;33(1):63-68. doi: 10.1016/j.jdiacomp.2018.09.020. Epub 2018 Oct 12.

PMID:
30621853
15.

Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease.

Zimbudzi E, Lo C, Ranasinha S, Fulcher G, Gallagher M, Jan S, Kerr PG, Teede HJ, Polkinghorne KR, Russell G, Walker RG, Zoungas S.

Health Qual Life Outcomes. 2018 Nov 19;16(1):215. doi: 10.1186/s12955-018-1044-2.

16.

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort.

Damasiewicz MJ, Lu ZX, Kerr PG, Polkinghorne KR.

BMC Nephrol. 2018 Nov 14;19(1):325. doi: 10.1186/s12882-018-1127-7.

17.

Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus.

Vincent FB, Kandane-Rathnayake R, Hoi AY, Slavin L, Godsell JD, Kitching AR, Harris J, Nelson CL, Jenkins AJ, Chrysostomou A, Hibbs ML, Kerr PG, Rischmueller M, Mackay F, Morand EF.

Lupus. 2018 Nov;27(13):2029-2040. doi: 10.1177/0961203318804885. Epub 2018 Oct 9.

PMID:
30301439
18.

Renal genetics in Australia: Kidney medicine in the genomic age.

Jayasinghe K, Quinlan C, Stark Z, Patel C, Mallawaarachchi A, Wardrop L, Kerr PG, Trnka P, Mallett AJ; KidGen Collaborative.

Nephrology (Carlton). 2019 Mar;24(3):279-286. doi: 10.1111/nep.13494. Epub 2018 Oct 18. Review.

19.

Nephrology in the Oceania-South East Asia region: perspectives and challenges.

Kerr PG, Tran HTB, Ha Phan HA, Liew A, Hooi LS, Johnson DW, Levin A; OSEA Regional Board.

Kidney Int. 2018 Sep;94(3):465-470. doi: 10.1016/j.kint.2018.05.014. Epub 2018 Jul 23. No abstract available.

PMID:
30045813
20.

Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysis.

Zimbudzi E, Lo C, Misso ML, Ranasinha S, Kerr PG, Teede HJ, Zoungas S.

Syst Rev. 2018 Jun 13;7(1):84. doi: 10.1186/s13643-018-0748-z.

21.

Biochemical comparison of 8 h haemodialysis and 4 h haemodiafiltration, and two dialysis membranes, in a randomized cross-over trial.

Choo SZ, Polkinghorne KR, Kerr PG.

Nephrology (Carlton). 2019 May;24(5):542-549. doi: 10.1111/nep.13397.

PMID:
29722110
22.

Use of deferasirox (Exjade) for iron overload in peritoneal dialysis patients.

Yii E, Doery JC, Kaplan Z, Kerr PG.

Nephrology (Carlton). 2018 Sep;23(9):887-889. doi: 10.1111/nep.13389.

PMID:
29663590
23.

Scope and Consistency of Outcomes Reported in Randomized Trials Conducted in Adults Receiving Hemodialysis: A Systematic Review.

Sautenet B, Tong A, Williams G, Hemmelgarn BR, Manns B, Wheeler DC, Tugwell P, van Biesen W, Winkelmayer WC, Crowe S, Harris T, Evangelidis N, Hawley CM, Pollock C, Johnson DW, Polkinghorne KR, Howard K, Gallagher MP, Kerr PG, McDonald SP, Ju A, Craig JC.

Am J Kidney Dis. 2018 Jul;72(1):62-74. doi: 10.1053/j.ajkd.2017.11.010. Epub 2018 Feb 21.

PMID:
29475768
24.

Models of care for co-morbid diabetes and chronic kidney disease.

Lo C, Zimbudzi E, Teede H, Cass A, Fulcher G, Gallagher M, Kerr PG, Jan S, Johnson G, Mathew T, Polkinghorne K, Russell G, Usherwood T, Walker R, Zoungas S.

Nephrology (Carlton). 2018 Aug;23(8):711-717. doi: 10.1111/nep.13232. Review.

PMID:
29405503
25.

Endothelial Progenitor Cells and Vascular Health in Dialysis Patients.

Huuskes BM, DeBuque RJ, Polkinghorne KR, Samuel CS, Kerr PG, Ricardo SD.

Kidney Int Rep. 2017 Sep 18;3(1):205-211. doi: 10.1016/j.ekir.2017.09.004. eCollection 2018 Jan. No abstract available.

26.

Preeclampsia and Long-term Renal Function in Women Who Underwent Kidney Transplantation.

Vannevel V, Claes K, Baud D, Vial Y, Golshayan D, Yoon EW, Hodges R, Le Nepveu A, Kerr PG, Kennedy C, Higgins M, Resch E, Klaritsch P, Van Mieghem T.

Obstet Gynecol. 2018 Jan;131(1):57-62. doi: 10.1097/AOG.0000000000002404.

PMID:
29215520
27.

Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.

Cho Y, Sautenet B, Rangan G, Craig JC, Ong ACM, Chapman A, Ahn C, Chen D, Coolican H, Kao JT, Gansevoort R, Perrone R, Harris T, Torres V, Pei Y, Kerr PG, Ryan J, Gutman T, Howell M, Ju A, Manera KE, Teixeira-Pinto A, Hamiwka LA, Tong A.

Trials. 2017 Nov 23;18(1):560. doi: 10.1186/s13063-017-2298-4.

28.

Preventing Intradialytic Hypotension: Translating Evidence into Practice.

Bradshaw W, Bennett PN, Ockerby C, Hutchinson AM, Kerr PG.

Nephrol Nurs J. 2017 Mar-Apr;44(2):131-151.

PMID:
29165964
29.

An Interview Study of Patient and Caregiver Perspectives on Advance Care Planning in ESRD.

Sellars M, Clayton JM, Morton RL, Luckett T, Silvester W, Spencer L, Pollock CA, Walker RG, Kerr PG, Tong A.

Am J Kidney Dis. 2018 Feb;71(2):216-224. doi: 10.1053/j.ajkd.2017.07.021. Epub 2017 Nov 11.

PMID:
29132946
30.

Olive (Olea europaea L.) Biophenols: A Nutriceutical against Oxidative Stress in SH-SY5Y Cells.

Omar SH, Kerr PG, Scott CJ, Hamlin AS, Obied HK.

Molecules. 2017 Oct 29;22(11). pii: E1858. doi: 10.3390/molecules22111858.

31.

Factors associated with patient activation in an Australian population with comorbid diabetes and chronic kidney disease: a cross-sectional study.

Zimbudzi E, Lo C, Ranasinha S, Fulcher GR, Jan S, Kerr PG, Polkinghorne KR, Russell G, Walker RG, Zoungas S.

BMJ Open. 2017 Oct 22;7(10):e017695. doi: 10.1136/bmjopen-2017-017695.

32.

Urolithiasis is prevalent and associated with reduced bone mineral density in β-thalassaemia major.

Wong P, Milat F, Fuller PJ, Kerr PG, Doery JCG, Oh DH, Jackson D, Gillespie MT, Bowden DK, Pasricha SR, Lau KK.

Intern Med J. 2017 Sep;47(9):1064-1067. doi: 10.1111/imj.13533.

PMID:
28891172
33.

Functional sustainability of periphytic biofilms in organic matter and Cu2+ removal during prolonged exposure to TiO2 nanoparticles.

Liu J, Tang J, Wan J, Wu C, Graham B, Kerr PG, Wu Y.

J Hazard Mater. 2019 May 15;370:4-12. doi: 10.1016/j.jhazmat.2017.08.068. Epub 2017 Aug 30.

PMID:
28886877
34.

Factors associated with foot ulceration and amputation in adults on dialysis: a cross-sectional observational study.

Kaminski MR, Raspovic A, McMahon LP, Lambert KA, Erbas B, Mount PF, Kerr PG, Landorf KB.

BMC Nephrol. 2017 Sep 8;18(1):293. doi: 10.1186/s12882-017-0711-6.

35.

The fragility of significant results underscores the need of larger randomized controlled trials in nephrology.

Shochet LR, Kerr PG, Polkinghorne KR.

Kidney Int. 2017 Dec;92(6):1469-1475. doi: 10.1016/j.kint.2017.05.011. Epub 2017 Jul 26.

PMID:
28754551
36.

Haemolysis in haemodialysis.

Tharmaraj D, Kerr PG.

Nephrology (Carlton). 2017 Nov;22(11):838-847. doi: 10.1111/nep.13119. Review.

PMID:
28749067
37.

Sustained High Nutrient Supply As an Allelopathic Trigger between Periphytic Biofilm and Microcystis aeruginosa.

Wu Y, Tang J, Liu J, Graham B, Kerr PG, Chen H.

Environ Sci Technol. 2017 Sep 5;51(17):9614-9623. doi: 10.1021/acs.est.7b01027. Epub 2017 Aug 11.

PMID:
28738143
38.

The association between patient activation and self-care practices: A cross-sectional study of an Australian population with comorbid diabetes and chronic kidney disease.

Zimbudzi E, Lo C, Ranasinha S, Kerr PG, Polkinghorne KR, Teede H, Usherwood T, Walker RG, Johnson G, Fulcher G, Zoungas S.

Health Expect. 2017 Dec;20(6):1375-1384. doi: 10.1111/hex.12577. Epub 2017 Jul 4.

39.

Home Hemodialysis: What Is Old Is New Again.

Kerr PG, Jaw J.

Contrib Nephrol. 2017;190:146-155. doi: 10.1159/000468961. Epub 2017 May 23. Review.

PMID:
28535526
40.

Serum phosphorus levels and fracture following renal transplantation.

Aleksova J, Wong P, Mulley WR, Choy KW, McLachlan R, Ebeling PR, Kerr PG, Milat F.

Clin Endocrinol (Oxf). 2017 Aug;87(2):141-148. doi: 10.1111/cen.13363. Epub 2017 Jun 1.

PMID:
28449252
41.

Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study.

Lo C, Teede H, Fulcher G, Gallagher M, Kerr PG, Ranasinha S, Russell G, Walker R, Zoungas S.

BMC Nephrol. 2017 Feb 28;18(1):80. doi: 10.1186/s12882-017-0493-x.

42.

Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey.

Evangelidis N, Tong A, Manns B, Hemmelgarn B, Wheeler DC, Tugwell P, Crowe S, Harris T, Van Biesen W, Winkelmayer WC, Sautenet B, O'Donoghue D, Tam-Tham H, Youssouf S, Mandayam S, Ju A, Hawley C, Pollock C, Harris DC, Johnson DW, Rifkin DE, Tentori F, Agar J, Polkinghorne KR, Gallagher M, Kerr PG, McDonald SP, Howard K, Howell M, Craig JC; Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Initiative.

Am J Kidney Dis. 2017 Oct;70(4):464-475. doi: 10.1053/j.ajkd.2016.11.029. Epub 2017 Feb 24.

PMID:
28238554
43.

Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.

Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR; Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group.

JAMA Intern Med. 2017 Feb 1;177(2):184-193. doi: 10.1001/jamainternmed.2016.8029.

44.

Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease.

Zimbudzi E, Lo C, Ranasinha S, Gallagher M, Fulcher G, Kerr PG, Russell G, Teede H, Usherwood T, Walker R, Zoungas S.

PLoS One. 2016 Dec 19;11(12):e0168491. doi: 10.1371/journal.pone.0168491. eCollection 2016.

45.

Evaluating role of immobilized periphyton in bioremediation of azo dye amaranth.

Shabbir S, Faheem M, Ali N, Kerr PG, Wu Y.

Bioresour Technol. 2017 Feb;225:395-401. doi: 10.1016/j.biortech.2016.11.115. Epub 2016 Dec 2.

PMID:
27956332
46.

Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL.

Zimbudzi E, Lo C, Ranasinha S, Kerr PG, Usherwood T, Cass A, Fulcher GR, Zoungas S.

J Diabetes Complications. 2017 Feb;31(2):427-432. doi: 10.1016/j.jdiacomp.2016.10.027. Epub 2016 Oct 29.

PMID:
27914731
47.

Reliability and validity of the coping strategy inventory-short form applied to hemodialysis patients in 13 countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Speyer E, Morgenstern H, Hayashino Y, Kerr PG, Rayner H, Robinson BM, Pisoni RL.

J Psychosom Res. 2016 Dec;91:12-19. doi: 10.1016/j.jpsychores.2016.08.015. Epub 2016 Oct 6.

PMID:
27894457
48.

Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study.

Packham DK, Fraser IR, Kerr PG, Segal KR.

EBioMedicine. 2016 Oct;12:263-269. doi: 10.1016/j.ebiom.2016.09.011. Epub 2016 Sep 17.

49.

Periphyton biofilms: A novel and natural biological system for the effective removal of sulphonated azo dye methyl orange by synergistic mechanism.

Shabbir S, Faheem M, Ali N, Kerr PG, Wu Y.

Chemosphere. 2017 Jan;167:236-246. doi: 10.1016/j.chemosphere.2016.10.002. Epub 2016 Oct 8.

PMID:
27728882
50.

Conservative Management and End-of-Life Care in an Australian Cohort with ESRD.

Morton RL, Webster AC, McGeechan K, Howard K, Murtagh FE, Gray NA, Kerr PG, Germain MJ, Snelling P.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2195-2203. Epub 2016 Oct 3.

Supplemental Content

Support Center